Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03589508 · ClinicalTrials.gov registry record · NA
Testing A Couple-based Program for Alcohol Risk Reduction in the National Guard
A NA study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT03589508: Completed NA study, sponsored by University of Massachusetts, Worcester.
NCT03589508 is a NA study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03589508, a NA study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this project is to develop and test indicated prevention intervention to harness support and health promoting endeavors to address use of alcohol to cope with reintegration challenges in Massachusetts National Guard (MANG) service members.
Primary Outcome
Derived from Timeline Followback (TLFB)
Interventions
- BEHAVIORAL In-person sessions: ABCP_P
- BEHAVIORAL Video conference sessions: ABCP_T
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-07-01 |
| Est. Completion | 2019-03-25 |
| Phase | NA |
What the finished NCT03589508 record still lists
NCT03589508 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which In-person sessions: ABCP_P is the first listed.
NCT03589508 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03589508 about?
NCT03589508 is a clinical study titled "Testing A Couple-based Program for Alcohol Risk Reduction in the National Guard". The purpose of this project is to develop and test indicated prevention intervention to harness support and health promoting endeavors to address use of alcohol to cope with reintegration challenges in Massachusetts National Guard (MANG) service members.
What is the current status of trial NCT03589508?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2016-07-01. Estimated completion is 2019-03-25.
What interventions are being tested in trial NCT03589508?
The interventions under investigation include: In-person sessions: ABCP_P (BEHAVIORAL), Video conference sessions: ABCP_T (BEHAVIORAL).
Who is sponsoring clinical trial NCT03589508?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03589508's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI